| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/14651858.CD012428 |
| P2093 | author name string | Janus C Jakobsen | |
| Jakob S Jensen | |||
| William K Karlsson | |||
| P2860 | cites work | Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation | Q22305336 |
| Oral antiplatelet therapy for acute ischaemic stroke | Q24197866 | ||
| Industry sponsorship and research outcome | Q24202591 | ||
| Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks | Q24244298 | ||
| Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks | Q24245569 | ||
| Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack | Q24245863 | ||
| Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods | Q24288962 | ||
| Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis | Q24289436 | ||
| Sequential methods for random-effects meta-analysis | Q24289522 | ||
| Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients | Q24555072 | ||
| Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials | Q24645391 | ||
| Review and management of side effects associated with antiplatelet therapy for prevention of recurrent cerebrovascular events | Q37872648 | ||
| Atrial fibrillation pathophysiology: implications for management. | Q37956126 | ||
| Dipyridamole in antithrombotic treatment | Q38036051 | ||
| Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish survey. | Q38106663 | ||
| Current and new oral antithrombotics in non-valvular atrial fibrillation: a network meta-analysis of 79 808 patients. | Q38134680 | ||
| Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments. | Q38380461 | ||
| The Epidemiology of Atrial Fibrillation and Stroke. | Q38826745 | ||
| Discrepancy between guidelines for stroke prevention in atrial fibrillation and practice patterns in primary care. The nationwide French AFIGP survey | Q40794999 | ||
| Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation | Q42609899 | ||
| Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? | Q43707230 | ||
| Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study). | Q46939643 | ||
| Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials | Q47192223 | ||
| Anticoagulant treatment in atrial fibrillation | Q50733256 | ||
| Methods for combining randomized clinical trials: strengths and limitations. | Q52599212 | ||
| Arcsine test for publication bias in meta-analyses with binary outcomes. | Q53024164 | ||
| Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study. | Q53352979 | ||
| Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. | Q54114563 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation | Q26747263 | ||
| Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010 | Q27015585 | ||
| 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society | Q27341873 | ||
| GRADE: an emerging consensus on rating quality of evidence and strength of recommendations | Q27860753 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860868 | ||
| Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study | Q28171184 | ||
| Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS) | Q28190393 | ||
| Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial | Q28194227 | ||
| Should aspirin be continued in patients started on warfarin? | Q28199065 | ||
| Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials | Q28200013 | ||
| Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials | Q28218081 | ||
| Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial | Q28219363 | ||
| Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation | Q28219547 | ||
| Atrial fibrillation as an independent risk factor for stroke: the Framingham Study | Q29614200 | ||
| A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints | Q29614902 | ||
| Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? | Q29619328 | ||
| Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses | Q33372680 | ||
| Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis | Q33744558 | ||
| Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs | Q33815844 | ||
| Apixaban in patients with atrial fibrillation | Q34163710 | ||
| Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review. | Q34359420 | ||
| Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. | Q34395380 | ||
| Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association | Q34505315 | ||
| Stroke severity in atrial fibrillation. The Framingham Study | Q34735226 | ||
| Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited | Q34919089 | ||
| Global epidemiology of atrial fibrillation | Q35223184 | ||
| Prevention of cardioembolic stroke | Q35648111 | ||
| Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q35752619 | ||
| Antiplatelet therapy as a modulator of stroke aetiology: a meta-analysis | Q36072444 | ||
| WITHDRAWN: Antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks | Q36884887 | ||
| Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses | Q37138228 | ||
| Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review. | Q37163258 | ||
| Antithrombotic treatment for the primary prevention of stroke in patients with non valvular atrial fibrillation: a reappraisal of the evidence and network meta analysis | Q37671330 | ||
| P921 | main subject | Atrial Fibrillation | Q815819 |
| P577 | publication date | 2016-11-08 | |
| P1476 | title | Antiplatelet therapy for preventing stroke in people with atrial fibrillation |
Search more.